Hot stock: UG Healthcare up 9% after Malaysia EPF Board raises stake
DeeperDive is a beta AI feature. Refer to full articles for the facts.
SHARES of Malaysian glove manufacturer UG Healthcare Corporation jumped on Monday amid active trading, following news that the Employees Provident Fund (EPF) Board of Malaysia had become a substantial shareholder with a direct interest of 5.29 per cent, up from its previous 4.99 per cent stake.
The stock began the day at S$0.96 before reaching a high of S$1.04 at 1.16pm. It was trading at S$1.02 as at 3.51pm, up S$0.085 or 9.1 per cent from Friday's close.
About 38.8 million shares worth S$38.7 million changed hands. The stock was the most traded by volume on the Singapore bourse on Monday, and the second most traded by value.
The EPF Board had acquired 605,000 UG Healthcare shares on the open market at an average price of S$2.55 apiece for a total consideration of about S$1.5 million, Catalist-listed UG Healthcare said in a regulatory filing last Thursday. (see amendment note)
Before its stock split which took effect on Friday, the counter last traded at S$2.55 last Tuesday. When proposing the stock split in August, UG Healthcare said then that the move would enhance its trading liquidity and broaden its shareholder base.
Meanwhile, the EPF Board also became a substantial shareholder of mainboard-listed Riverstone Holdings, UG Healthcare's glove-making peer, on Sept 17.
Navigate Asia in
a new global order
Get the insights delivered to your inbox.
Amendment note: An earlier version of this article wrongly stated that UG Healthcare is mainboard-listed. It is in fact Catalist-listed.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Autobahn Rent A Car directors declared bankrupt over S$50 million each owed to DBS
Higher costs, lower returns: Why are Singaporeans still betting on real estate?
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant
Loyang Valley sold for S$880 million to SingHaiyi-led consortium